# A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas

> **NCT02302950** · — · UNKNOWN · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 254 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** raltegravir

## Key facts

- **NCT ID:** NCT02302950
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2015-12
- **Final completion:** 2017-12
- **Target enrollment:** 254 (ACTUAL)
- **Last updated:** 2017-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02302950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02302950, "A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02302950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
